Torgny Wilcke

Medicine & Life Sciences

1. Chronic Obstructive Pulmonary Disease 100%
2. Noninvasive Ventilation 27%
3. Respiratory Insufficiency 24%
4. Adrenal Cortex Hormones 23%
5. Lung 22%
6. Lung Diseases 20%
7. Pseudomonas aeruginosa 19%
8. Rehabilitation 19%
9. Tuberculosis 18%
10. Denmark 17%
11. Telerehabilitation 16%
12. Disease Progression 15%
13. Hydroxychloroquine 14%
14. Mortality 13%
15. Cohort Studies 13%
16. Azithromycin 12%
17. Randomized Controlled Trials 12%
18. Eosinophils 10%
19. Hospitalization 10%
20. Therapeutics 9%
21. Outpatients 9%
22. Isoniazid 9%
23. Chronic Disease 8%
24. Biomarkers 8%
25. Retrospective Studies 7%
26. alpha 1-Antitrypsin Deficiency 7%
27. West Nile Fever 7%
28. Contact Tracing 7%
29. Bronchiectasis 7%
30. Equivalence Trials 7%
31. Quality of Life 7%
32. Patient Readmission 6%
33. Smokers 6%
34. Hospital Mortality 6%
35. Coronavirus 6%
36. Lung Neoplasms 6%
37. Idiopathic Pulmonary Fibrosis 6%
38. Interstitial Lung Diseases 6%
39. Patient Selection 6%
40. Thorax 5%
41. Anti-Bacterial Agents 5%
42. Israel 5%
43. Glucocorticoid Receptors 5%
44. Venous Thromboembolism 5%
45. Bronchoscopy 5%
46. Task Performance and Analysis 5%
47. Acetylation 5%
48. Guidelines 5%
49. Bone Remodeling 5%
50. Prednisolone 5%